• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    Seattle Genetics, Inc. (SGEN)

    -NasdaqGS
    28.64 Up 1.60(5.92%) 4:00PM EST
    |After Hours : 28.92 Up 0.28 (0.98%) 5:03PM EST - Nasdaq Real Time Price
    Prev Close:27.04
    Open:27.54
    Bid:25.78 x 100
    Ask:29.00 x 600
    1y Target Est:48.27
    Beta:2.00616
    Earnings Date:Apr 28 - May 2 (Est.)
    Day's Range:26.98 - 28.70
    52wk Range:26.02 - 52.33
    Volume:1,518,281
    Avg Vol (3m):1,206,360
    Market Cap:3.99B
    P/E (ttm):N/A
    EPS (ttm):-0.98
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SGEN

    Comparison

    Symbol% ChgMkt Cap
    SGENUp 5.92%3.99B
    IMGNUp 2.68%633.80M
    PFEUp 0.79%181.25B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):11.20
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.95
    Quarterly EPS Est (Mar-16) :-0.09
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):-1.64

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Seattle Genetics, Inc., a biotechnology company, develops and commercializes antibody-based therapies for the treatment of cancer. The company is developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback